Arteriosclerosis and Thrombosis, Vol 14, 460-464, Copyright © 1994 by American Heart Association

ARTICLES

Effects of age, lipoproteins, and hemostatic parameters on the role of homocyst(e)inemia as a cardiovascular risk factor in men

A von Eckardstein, MR Malinow, B Upson, J Heinrich, H Schulte, R Schonfeld, E Kohler and G Assmann
Institut fur Klinische Chemie und Laboratoriumsmedizin, Zentrallaboratorium, Westfalische Wilhelms-Universitat Munster, FRG.

Previous studies have identified moderately elevated plasma concentrations of homocyst(e)ine as an independent risk factor for coronary heart disease (CHD). The atherogenicity of homocyst(e)ine has mostly been attributed to its effects on endothelial cells, platelets, and the hemostatic system. In this case-control study of 199 male CHD patients and 156 age-matched control subjects, we analyzed the role of homocyst(e)ine as a cardiovascular risk marker in the context of traditional risk factors as well as of plasma fibrinogen, plasminogen, and viscosity. Both univariate and multivariate regression analyses revealed that homocyst(e)ine levels were significantly correlated with age, fibrinogen, and plasma viscosity in both study groups. Geometric mean homocyst(e)ine levels by univariate analysis were significantly higher in patients than in control subjects (8.9 versus 7.8 mumol/L, P < .001). This difference remained significant on multiple logistic function analysis after being adjusted for body mass index, systolic blood pressure, serum cholesterol, and high-density lipoprotein cholesterol but not after additional adjustment for fibrinogen. By contrast, geometric mean fibrinogen levels after adjustment for homocyst(e)ine levels were significantly different between patients and control subjects (296.4 versus 230.8 mg/dL, P < .001). Within the group of CHD patients, both fibrinogen and homocyst(e)ine significantly increased in parallel with the number of stenosed coronary vessels. We conclude that hyperhomocyst(e)inemia is an independent coronary risk factor and that its interrelation with fibrinogen levels merits further study.

This article has been cited by other articles:

				S. K. Park, M. S. O'Neill, P. S. Vokonas, D. Sparrow, A. Spiro III, K. L. Tucker, H. Suh, H. Hu, and J. Schwartz Traffic-related Particles Are Associated with Elevated Homocysteine: The VA Normative Aging Study Am. J. Respir. Crit. Care Med., August 1, 2008; 178(3): 283 - 289. [Abstract] [Full Text] [PDF]

				G. Vrentzos, J. A. Papadakis, N. Malliaraki, E. A. Zacharis, K. Katsogridakis, A. N. Margioris, P. E. Vardas, and E. S. Ganotakis Association of Serum Total Homocysteine with the Extent of Ischemic Heart Disease in a Mediterranean Cohort Angiology, September 1, 2004; 55(5): 517 - 524. [Abstract] [PDF]

				A. Bosy-Westphal, M. Ruschmeyer, N. Czech, G. Oehler, H. Hinrichsen, M. Plauth, E. Lotterer, W. Fleig, and M. J. Muller Determinants of hyperhomocysteinemia in patients with chronic liver disease and after orthotopic liver transplantation Am. J. Clinical Nutrition, May 1, 2003; 77(5): 1269 - 1277. [Abstract] [Full Text] [PDF]

				Homocysteine Studies Collaboration Homocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis JAMA, October 23, 2002; 288(16): 2015 - 2022. [Abstract] [Full Text] [PDF]

				N. Weiss, C. Keller, U. Hoffmann, and J. Loscalzo Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia Vascular Medicine, August 1, 2002; 7(3): 227 - 239. [Abstract] [PDF]

				E. S Ford, S J. Smith, D. F Stroup, K. K Steinberg, P. W Mueller, and S. B Thacker Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies Int. J. Epidemiol., February 1, 2002; 31(1): 59 - 70. [Abstract] [Full Text] [PDF]

				J. A. Tice, E. Ross, P. G. Coxson, I. Rosenberg, M. C. Weinstein, M. G. M. Hunink, P. A. Goldman, L. Williams, and L. Goldman Cost-effectiveness of Vitamin Therapy to Lower Plasma Homocysteine Levels for the Prevention of Coronary Heart Disease: Effect of Grain Fortification and Beyond JAMA, August 22, 2001; 286(8): 936 - 943. [Abstract] [Full Text] [PDF]

				C. W. Compher, B. P. Kinosian, N. Evans-Stoner, J. Huzinec, and G. P. Buzby Hyperhomocysteinemia Is Associated with Venous Thrombosis in Patients with Short Bowel Syndrome JPEN J Parenter Enteral Nutr, January 1, 2001; 25(1): 1 - 8. [Abstract] [PDF]

				G. L. Booth, E. E.L. Wang, and with the Canadian Task Force on Preventive Health Preventive health care, 2000 update: screening and management of hyperhomocysteinemia for the prevention of coronary artery disease events Can. Med. Assoc. J., July 1, 2000; 163(1): 21 - 29. [Abstract] [Full Text] [PDF]

				W. G. Christen, U. A. Ajani, R. J. Glynn, and C. H. Hennekens Blood Levels of Homocysteine and Increased Risks of Cardiovascular Disease: Causal or Casual? Arch Intern Med, February 28, 2000; 160(4): 422 - 434. [Abstract] [Full Text] [PDF]

				V. Fonseca, S. C. Guba, and L. M. Fink Hyperhomocysteinemia and the Endocrine System: Implications for Atherosclerosis and Thrombosis Endocr. Rev., October 1, 1999; 20(5): 738 - 759. [Abstract] [Full Text]

				P H Whincup, H Refsum, I J Perry, R Morris, M Walker, L Lennon, A Thomson, P M Ueland, and S B J Ebrahim Serum total homocysteine and coronary heart disease: prospective study in middle aged men Heart, October 1, 1999; 82(4): 448 - 454. [Abstract] [Full Text] [PDF]

				K. Kunz, P. Petitjean, M. Lisri, F. Chantrel, C. Koehl, M.-L. Wiesel, J.-P. Cazenave, B. Moulin, and T. P. Hannedouche Cardiovascular morbidity and endothelial dysfunction in chronic haemodialysis patients: is homocyst(e)ine the missing link? Nephrol. Dial. Transplant., August 1, 1999; 14(8): 1934 - 1942. [Abstract] [Full Text] [PDF]

				S. K. Osganian, M. J. Stampfer, D. Spiegelman, E. Rimm, J. A. Cutler, H. A. Feldman, D. H. Montgomery, L. S. Webber, L. A. Lytle, L. Bausserman, et al. Distribution of and Factors Associated With Serum Homocysteine Levels in Children: Child and Adolescent Trial for Cardiovascular Health JAMA, April 7, 1999; 281(13): 1189 - 1196. [Abstract] [Full Text] [PDF]

				C. D. A. Stehouwer, M. P. Weijenberg, M. van den Berg, C. Jakobs, E. J. M. Feskens, and D. Kromhout Serum Homocysteine and Risk of Coronary Heart Disease and Cerebrovascular Disease in Elderly Men : A 10-Year Follow-Up Arterioscler Thromb Vasc Biol, December 1, 1998; 18(12): 1895 - 1901. [Abstract] [Full Text] [PDF]

				W. H. Giles, J. B. Croft, K. J. Greenlund, E. S. Ford, and S. J. Kittner Total Homocyst(e)ine Concentration and the Likelihood of Nonfatal Stroke : Results From the Third National Health and Nutrition Examination Survey, 1988–1994 Stroke, December 1, 1998; 29(12): 2473 - 2477. [Abstract] [Full Text] [PDF]

				J. M. Stern, J. L. Saver, R. M. Boldy, and F. DeGregorio Homocysteine Associated Hypercoagulability and Disseminated Thrombosis: A Case Report Angiology, October 1, 1998; 49(10): 765 - 769. [Abstract] [PDF]

				J. H. Stein and P. E. McBride Hyperhomocysteinemia and Atherosclerotic Vascular Disease: Pathophysiology, Screening, and Treatment Arch Intern Med, June 22, 1998; 158(12): 1301 - 1306. [Abstract] [Full Text] [PDF]

				N. J. Wald, H. C. Watt, M. R. Law, D. G. Weir, J. McPartlin, and J. M. Scott Homocysteine and Ischemic Heart Disease: Results of a Prospective Study With Implications Regarding Prevention Arch Intern Med, April 27, 1998; 158(8): 862 - 867. [Abstract] [Full Text] [PDF]

				S. Moll, D. Farhadi, A. von Eckardstein, G. Assmann, O. Nygard, H. Refsum, P. M. Ueland, M. Farstad, S. E. Vollset, and J. E. Nordrehaug Plasma Homocysteine Levels and Mortality in Patients with Coronary Artery Disease N. Engl. J. Med., November 27, 1997; 337(22): 1631 - 1633. [Full Text]

				R. W. Evans, B. J. Shaten, J. D. Hempel, J. A. Cutler, and L. H. Kuller Homocyst(e)ine and Risk of Cardiovascular Disease in the Multiple Risk Factor Intervention Trial Arterioscler Thromb Vasc Biol, October 1, 1997; 17(10): 1947 - 1953. [Abstract] [Full Text]

				P. Verhoef, F. J. Kok, D. A.C.M. Kruyssen, E. G. Schouten, J. C.M. Witteman, D. E. Grobbee, P. M. Ueland, and H. Refsum Plasma Total Homocysteine, B Vitamins, and Risk of Coronary Atherosclerosis Arterioscler Thromb Vasc Biol, May 1, 1997; 17(5): 989 - 995. [Abstract] [Full Text]

				M. van den Berg, C. D.A. Stehouwer, E. Bierdrager, and J. A. Rauwerda Plasma Homocysteine and Severity of Atherosclerosis in Young Patients With Lower-Limb Atherosclerotic Disease Arterioscler Thromb Vasc Biol, January 1, 1996; 16(1): 165 - 171. [Abstract] [Full Text]

				C. J. Boushey, S. A. A. Beresford, G. S. Omenn, and A. G. Motulsky A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease: Probable Benefits of Increasing Folic Acid Intakes JAMA, October 4, 1995; 274(13): 1049 - 1057. [Abstract] [PDF]

				P. N. Hopkins, L. L. Wu, J. Wu, S. C. Hunt, B. C. James, G. M. Vincent, and R. R. Williams Higher Plasma Homocyst(e)ine and Increased Susceptibility to Adverse Effects of Low Folate in Early Familial Coronary Artery Disease Arterioscler Thromb Vasc Biol, September 1, 1995; 15(9): 1314 - 1320. [Abstract] [Full Text]